Professor of Radiation Oncology, University Tex Houston
Radiation Oncology
Dr. Zhongxing Liao, MD
|
|
Give Review
Doctor Zhongxing Liao, MD works in the field of Radiation Oncology. He studied medicine at Hunan Medical University. He over the years received 1 awards: "Top Doctors:SE Texas". Zhongxing Liao is a published physician. He published 79 publications, including: 'Prospective Study of Patient-Reported Symptom Burden in Patients with Non-Small Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy.' Zhongxing Liao accepts Medicare.
Publications
- Lung Size and the Risk of Radiation Pneumonitis.
- Objectively Quantifying Radiation Esophagitis With Novel Computed Tomography-Based Metrics.
- Potential Use of (18)F-fluorodeoxyglucose Positron Emission Tomography-Based Quantitative Imaging Features for Guiding Dose Escalation in Stage III Non-Small Cell Lung...
- Prospective Study of Patient-Reported Symptom Burden in Patients with Non-Small Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy.
- NSCLC tumor shrinkage prediction using quantitative image features.
- Comparison of Locoregional versus Extended Locoregional Radiation Volumes for Patients with Nonmetastatic Gastro-Esophageal Junction Carcinomas.
- A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal Cancer.
- Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung Cancer patients.
- Early experience with intensity modulated proton therapy for Lung-intact mesothelioma: A case series.
- Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung Cancer.
- Hemithoracic Intensity Modulated Radiation Therapy After Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Toxicity, Patterns of Failure, and a Matched Sur...
- Use of Simultaneous Radiation Boost Achieves High Control Rates in Patients With Non-Small-Cell Lung Cancer Who Are Not Candidates for Surgery or Conventional Chemorad...
- Prospective exploratory Analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure.
- Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung Cancers.
- Incidental Receipt of Cardiac Medications and Survival Outcomes Among Patients With Stage III Non-Small-Cell Lung Cancer After Definitive Radiotherapy.
- Clinical Implementation of Intensity Modulated Proton Therapy for Thoracic Malignancies.
- Re-evaluating the Optimal Radiation Dose for Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
- Propensity Score-Matched Analysis of Comprehensive Local Therapy for Oligometastatic Non-Small Cell Lung Cancer That Did Not Progress After Front-Line Chemotherapy.
- Prognostic Value and Reproducibility of Pretreatment CT Texture Features in Stage III Non-Small Cell Lung Cancer.
- Definitive Reirradiation for Locoregionally Recurrent Non-Small Cell Lung Cancer With Proton Beam Therapy or Intensity Modulated Radiation Therapy: Predictors of High-...
- Lymphopenia association with gross tumor volume and lung v5 and its effects on non-small cell lung Cancer patient outcomes.
- Couple-based Tibetan yoga program for lung Cancer patients and their caregivers.
- Tibetan yoga can help people with lung Cancer and their caregivers.
- Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung Cancer treated with definitive radiation therapy.
- Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer.
- Influence of preoperative radiation field on postoperative leak rates in esophageal Cancer patients after trimodality therapy.
- Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung Cancer.
- On the interplay effects with proton scanning beams in stage III lung Cancer.
- Acute phase response before treatment predicts radiation esophagitis in non-small cell lung Cancer.
- Patient-specific quantification of respiratory motion-induced dose uncertainty for step-and-shoot IMRT of lung Cancer.
- Associations between Single-Nucleotide Polymorphisms in the PI3K-PTEN-AKT-mTOR Pathway and Increased Risk of Brain Metastasis in Patients with Non-Small Cell Lung Cancer.
- Factors Associated with Local-Regional Failure After Definitive Chemoradiation for Locally Advanced Esophageal Cancer.
- Effects of Respiratory Motion on Passively Scattered Proton Therapy Versus Intensity Modulated Photon Therapy for Stage III Lung Cancer: Are Proton Plans More Sensitiv...
- Automatic contouring of brachial plexus using a multi-atlas approach for lung Cancer radiotherapy.
- Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung Cancer.
- Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung Cancer.
- Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort.
- Predictors of postoperative complications after trimodality therapy for esophageal Cancer.
- Phase 1 Study of Dose Escalation in Hypofractionated Proton Beam Therapy for Non-Small Cell Lung Cancer.
- Balancing radiation pneumonitis versus locoregional tumor control in non-small-cell lung Cancer.
- Obesity and outcomes in patients treated with chemoradiotherapy for Esophageal carcinoma.
- Use of 4-Dimensional Computed Tomography-Based Ventilation Imaging to Correlate Lung Dose and Function With Clinical Outcomes.
- Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for Malignant pleural mesothelioma.
- Predicting pneumonitis risk: a dosimetric alternative to mean Lung dose.
- Functional Promoter Variant rs2868371 of HSPB1 Is Associated With Risk of Radiation Pneumonitis After Chemoradiation for Non-Small Cell Lung Cancer.
- Prognostic value of patient-reported symptom interference in patients with late-stage lung Cancer.
- Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non-Small-Cell Lung Cancer.
- Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung Cancer treated with definitive radiation therapy.
- Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung Cancer, with implications for patient selection for adjuvant radiati...
- ATM Polymorphisms Predict Severe Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy.
- Prescribing radiation dose to lung Cancer patients based on personalized toxicity estimates.
- Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung Cancer.
- Automated Volumetric Modulated Arc Therapy Treatment Planning for Stage III Lung Cancer: How Does It Compare With Intensity-Modulated Radio Therapy?
- Predictors of High-grade Esophagitis After Definitive Three-dimensional Conformal Therapy, Intensity-modulated Radiation Therapy, or Proton Beam Therapy for Non-small ...
- Propensity Score-based Comparison of Long-term Outcomes With 3-Dimensional Conformal Radiotherapy vs Intensity-Modulated Radiotherapy for Esophageal Cancer.
- Change in Diffusing Capacity After Radiation as an Objective Measure for Grading Radiation Pneumonitis in Patients Treated for Non-Small-Cell Lung Cancer.
- Reducing the toxicity of Cancer therapy: recognizing needs, taking action.
- Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal Cancer undergoing chemoradiation therapy.
- Mitigation and Treatment of Radiation-Induced Thoracic Injury With a Cyclooxygenase-2 Inhibitor, Celecoxib.
- SU-E-T-394: Comparison of Planned Dose Distribution Vs. DeLivered Dose Distribution for Both IMRT and Proton Therapy Using Weekly Repeat 4DCT Data Sets.
- HSPB1 Gene Polymorphisms Predict Risk of Mortality for US Patients after Radio(chemo)therapy for Non-Small Cell Lung Cancer.
- Incorporating Single-nucleotide Polymorphisms Into the Lyman Model to Improve Prediction of Radiation Pneumonitis.
- Prognostic Impact of Radiation Therapy to the Primary Tumor in Patients With Non-small Cell Lung Cancer and Oligometastasis at Diagnosis.
- A novel method to incorporate the spatial location of the Lung dose distribution into predictive radiation pneumonitis modeling.
- Changes in Pulmonary Function after Three-Dimensional Conformal Radiotherapy, Intensity-Modulated Radiotherapy, or Proton Beam Therapy for Non-Small-Cell Lung Cancer.
- Proton Beam Therapy and Concurrent Chemotherapy for Esophageal Cancer.
- Patterns of care and locoregional treatment outcomes in older esophageal Cancer patients: The SEER-Medicare Cohort.
- The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung Cancer after chemoradiation therapy.
- Impact of using different four-dimensional computed tomography data sets to design proton treatment plans for distal esophageal Cancer.
- Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III...
- Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung Cancer.
- Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung Cancer in a clinical setting.
- Automatic contouring of brachial plexus using a multi-atlas approach for lung Cancer radiation therapy.
- What Would Be the Most Appropriate α/β Ratio in the Setting of Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer.
- Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung Cancer.
- Analysis of esophageal-sparing treatment plans for patients with high-grade esophagitis.
- A technique to use CT images for in vivo detection and quantification of the spatial distribution of radiation-induced esophagitis.
- Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal Cancer.
Schools
Hunan Medical College
University of Kansas School of Medicine
MD Anderson Canc Center
Hunan Med U
Mdacc
Procedures Preformed
- Brachytherapy
- Cancer Treatment
- External Beam Radiotherapy
- General External Beam Radiation Therapy
- View All
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Cancer
- Colorectal Cancer
- View All
Doctors Specialties
- Radiation Oncology
- Thoracic Oncology
Accepted Insurances
- Choice Plus POS II
- Blue Cross Blue Shield
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- United Healthcare
Awards
- Top Doctors:SE Texas
Education
-
University of Texas MD Anderson Cancer Center -
University of Kansas at Wichita -
Hunan Medical University
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1316048465 | |
| NPPES Provider LastName | LIAO | |
| NPPES Provider FirstName | ZHONGXING | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 78.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 20.51 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316048465 |
| Last Name Of The Provider | LIAO |
| First Name Of The Provider | ZHONGXING |
| View All |
Similar Doctors
|
Dr. Angel I. Blanco, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory Chronowski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James W. Welsh, MD |
|
|
Dr. Robert S. Bradfield, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melenda D. Jeter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clifton D. Fuller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luka Milas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cameron H. Swanick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angela W. Zhu, MD
This Doctor is OpenDoctor Recommended.
|